Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:23 pm Sale |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
BRIDGER MANAGEMENT LLC | 60,990 1.800% |
-56,324 (-48.01%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 314,545 9.900% |
94,780 (+43.13%) |
Filing History |
| 2021-02-16 1:41 pm Purchase |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Maverick Capital, Ltd. | 292,982 8.900% |
94,644 (+47.72%) |
Filing History |
| 2021-02-16 08:19 am Sale |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Camber Capital Management LP | 0 0.000% |
-118,000 (Position Closed) |
Filing History |
| 2021-02-12 3:12 pm Purchase |
2020-02-12 | 13G | Atara Biotherapeutics, Inc. ATRA |
BAUPOST GROUP LLC/MA | 364,360 11.070% |
32,004 (+9.63%) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
The Vanguard Group | 225,531 6.850% |
78,263 (+53.14%) |
Filing History |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
BlackRock Inc. BLK |
258,177 7.800% |
74,960 (+40.91%) |
Filing History |
| 2021-01-08 11:43 am Purchase |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
JPMORGAN CHASE & CO JPM |
241,140 7.300% |
241,140 (New Position) |
Filing History |